Verve Therapeutics Inc (VERV)
6.595
-0.28
(-4.14%)
USD |
NASDAQ |
Apr 24, 16:00
6.595
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Total Assets (Quarterly): 752.69M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 752.69M |
| September 30, 2023 | 612.41M |
| June 30, 2023 | 589.13M |
| March 31, 2023 | 634.38M |
| December 31, 2022 | 679.22M |
| September 30, 2022 | 673.36M |
| June 30, 2022 | 324.27M |
| Date | Value |
|---|---|
| March 31, 2022 | 349.24M |
| December 31, 2021 | 384.12M |
| September 30, 2021 | 410.88M |
| June 30, 2021 | 426.52M |
| March 31, 2021 | 158.17M |
| December 31, 2020 | 78.41M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
78.41M
Minimum
Dec 2020
752.69M
Maximum
Dec 2023
467.14M
Average
426.52M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Acorda Therapeutics Inc | 108.52M |
| Eli Lilly and Co | 64.01B |
| Intellia Therapeutics Inc | 1.301B |
| Beam Therapeutics Inc | 1.460B |
| Gritstone Bio Inc | 177.77M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 153.19M |
| Shareholders Equity (Quarterly) | 599.50M |
| Current Ratio | 17.24 |